| Pharmaceutical Information |
| Drug Name |
Sulfinpyrazone |
| Drug ID |
BADD_D02094 |
| Description |
A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. |
| Indications and Usage |
For the treatment of gout and gouty arthritis. |
| Marketing Status |
Discontinued |
| ATC Code |
M04AB02 |
| DrugBank ID |
DB01138
|
| KEGG ID |
D00449
|
| MeSH ID |
D013442
|
| PubChem ID |
5342
|
| TTD Drug ID |
D03DEI
|
| NDC Product Code |
Not Available |
| Synonyms |
Sulfinpyrazone | Sulphinpyrazone | Sulfoxyphenylpyrazolidin | Nu-Sulfinpyrazone | Nu Sulfinpyrazone | Anturane | Anturan | Apo-Sulfinpyrazone | Apo Sulfinpyrazone |
|
| Chemical Information |
| Molecular Formula |
C23H20N2O3S |
| CAS Registry Number |
57-96-5 |
| SMILES |
C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
